IUSZ 📈 iShares Public Limited - - Overview

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE0005042456 • UK Large-Cap Equity

IUSZ: Index, Funds, ETF, Stocks, Bonds

The iShares Core FTSE 100 UCITS ETF, listed on XETRA under the ticker IUSZ, is a prominent exchange-traded fund (ETF) offered by iShares, a subsidiary of BlackRock, one of the world's leading asset management companies. This ETF is domiciled in Ireland, which provides a favorable regulatory environment for investment funds. The fund's primary objective is to track the performance of the FTSE 100 index, although it's worth noting that the provided index name is the Morningstar UK All Cap TME NR GBP, indicating a broader investment scope that encompasses a wide range of UK companies, not strictly limited to the large-cap segment of the FTSE 100.

With an ISIN of IE0005042456, this ETF is classified under the category of UK Large-Cap Equity, suggesting its focus on the larger, more established companies within the UK market. However, the mention of 'All Cap' in its index name suggests a strategy that may also include smaller capitalization stocks, providing a more comprehensive view of the UK equity market. As an ETF, it offers investors the benefits of diversification, liquidity, and transparency, making it an attractive option for those seeking to gain exposure to the UK stock market. The fund's structure as a UCITS (Undertakings for the Collective Investment in Transferable Securities) compliant ETF ensures that it adheres to a strict set of regulatory requirements, aimed at protecting investors and promoting transparency and liquidity.

The company behind this ETF, BlackRock, operates through its website at http://www.blackrock.com, providing a wealth of information for investors, including detailed product information, performance data, and educational resources. BlackRock's scale and expertise in asset management contribute to the efficiency and effectiveness of the iShares Core FTSE 100 UCITS ETF, making it a popular choice among investors seeking a low-cost, diversified investment vehicle for accessing the UK equity market. The ETF's listing on XETRA, a major European stock exchange, further enhances its accessibility and liquidity for a broad range of investors.

Additional Sources for IUSZ ETF

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

IUSZ ETF Overview

Market Cap in USD 10,328m
Category UK Large-Cap Equity
TER 0.07%
IPO / Inception 2000-04-27

IUSZ ETF Ratings

Growth 5y 53.2%
Fundamental -
Dividend 9.85%
Rel. Strength Industry -45.1
Analysts -
Fair Price Momentum 9.28 EUR
Fair Price DCF -

IUSZ Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y %
Annual Growth 5y -100.00%
Payout Consistency 58.6%

IUSZ Growth Ratios

Growth Correlation 3m 14.8%
Growth Correlation 12m 79.3%
Growth Correlation 5y 94.2%
CAGR 5y 4.43%
CAGR/Mean DD 5y 0.64
Sharpe Ratio 12m 0.48
Alpha -9.17
Beta 0.64
Volatility 14.11%
Current Volume 16.1k
Average Volume 20d 100.4k
What is the price of IUSZ stocks?
As of January 03, 2025, the stock is trading at EUR 9.51 with a total of 16,106 shares traded.
Over the past week, the price has changed by -0.38%, over one month by -2.76%, over three months by -1.26% and over the past year by +9.86%.
Is iShares Public Limited - a good stock to buy?
Partly, yes. Based on ValueRay Analyses, iShares Public Limited - (XETRA:IUSZ) is currently (January 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 53.19 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IUSZ as of January 2025 is 9.28. This means that IUSZ is currently overvalued and has a potential downside of -2.42%.
Is IUSZ a buy, sell or hold?
iShares Public Limited - has no consensus analysts rating.
What are the forecast for IUSZ stock price target?
According to ValueRays Forecast Model, IUSZ iShares Public Limited - will be worth about 10.2 in January 2026. The stock is currently trading at 9.51. This means that the stock has a potential upside of +7.26%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 10.2 7.3%